- Nachrichtendetail
-
10.06.2024 14:01:53 - dpa-AFX: *ABBOTT GETS FDA CLEARANCE FOR TWO NEW OVER-THE-COUNTER CONTINUOUS GLUCOSE MONITORING SYSTEMS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Abbott Laboratories | 850103 | NYSE | 105,054 | 26.06.24 20:46:58 | -0,436 | -0,41% | 105,050 | 105,070 | 105,090 | 105,490 |
